NYSE:MDP Meredith (MDP) Stock Price, News & Analysis → Why Big Pharma is Investing Billions in This Biotech (From Behind the Markets) (Ad) Free MDP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$58.04▼$59.0752-Week Range N/AVolume3.36 million shsAverage Volume552,848 shsMarket Capitalization$2.70 billionP/E Ratio10.01Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Meredith alerts: Email Address Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details About Meredith Stock (NYSE:MDP)Meredith Corp. engages in television broadcasting and magazine advertising business. It operates through the Local Media and National Media business segments. The Local Media segment includes television stations and offers websites, mobile-optimized websites, and mobile applications. The National Media segment consists of national consumer media brands delivered via multiple media platforms including print magazines and digital and mobile media, brand licensing activities, database-related activities, and business-to-business marketing products and services. The company was founded by Edwin Thomas Meredith in 1902 and is headquartered in Des Moines, IA.Read More Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details MDP Stock News HeadlinesNovember 8, 2023 | investorplace.comLegendary Investor Meredith Whitney Just Issued a Big Housing Market WarningJanuary 31, 2023 | finance.yahoo.comMedexus Pharmaceuticals Inc. (TSE:MDP): Are Analysts Optimistic?April 27, 2024 | Crypto Swap Profits (Ad)Did You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.November 11, 2022 | finance.yahoo.comMedexus Pharmaceuticals Second Quarter 2023 Earnings: Beats ExpectationsNovember 8, 2022 | finance.yahoo.comMedexus Announces Strongest Quarter in Company History with Fiscal Q2 2023 Revenue of US$27.7 Million, a 55% Increase Over Fiscal Q2 2022October 6, 2022 | finance.yahoo.comMedexus Announces Preliminary Revenue Results for Second Fiscal Quarter 2023September 19, 2022 | finance.yahoo.comMedexus Provides Update on Treosulfan NDA Resubmission and Provides Business UpdateSeptember 15, 2022 | finance.yahoo.comMedexus Holds Annual Meeting of Shareholders and Announces Election of Board of DirectorsApril 27, 2024 | Crypto Swap Profits (Ad)Did You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.August 17, 2022 | theglobeandmail.comMedexus Pharma MDP is in the bottom 25 performing stocks year-to-date on the Toronto Stock ExchangeAugust 9, 2022 | seekingalpha.comMedexus Pharmaceuticals Inc. (MEDXF) CEO Ken d'Entremont on Q1 2023 Results - Earnings Call TranscriptAugust 8, 2022 | finance.yahoo.comMedexus Announces Record Fiscal Q1 2023 Revenue of US$23.0 Million, a 33% Increase versus Fiscal Q1 2022November 23, 2021 | finance.yahoo.comMeredith Corporation Announces Winners of Good Impressions ProgramOctober 9, 2021 | benzinga.comWhat Does Meredith's Debt Look Like?October 8, 2021 | finance.yahoo.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Meredith Corporation (NYSE - MDP)See More Headlines Receive MDP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Meredith and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings10/28/2021Today4/27/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorConsumer Staples Industry Periodicals Sub-IndustryPublishing Current SymbolNYSE:MDP CUSIP58943310 CIK65011 Webwww.meredith.com Phone(515) 284-3000Fax515-284-2700Employees5,330Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$5.90 Trailing P/E Ratio10.01 Forward P/E RatioN/A P/E GrowthN/ANet Income$306.60 million Net Margins9.66% Pretax Margin13.12% Return on Equity41.72% Return on Assets4.92% Debt Debt-to-Equity Ratio4.03 Current Ratio1.39 Quick Ratio1.36 Sales & Book Value Annual Sales$2.98 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow5.68 Book Value$14.27 per share Price / BookN/AMiscellaneous Outstanding Shares45,781,000Free Float41,299,000Market Cap$2.70 billion OptionableOptionable Beta2.07 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesThomas H. HartyChairman, President & Chief Executive OfficerJason M. FrierottChief Financial & Accounting OfficerMichael BrownsteinChief Revenue Officer & Executive Vice PresidentSteven M. CappaertSenior Vice President & ControllerCharlie HenrichVice President & General ManagerKey CompetitorsGrocery OutletNASDAQ:GOJ&J Snack FoodsNASDAQ:JJSFUtz BrandsNYSE:UTZVestisNYSE:VSTSNewell BrandsNASDAQ:NWLView All Competitors MDP Stock Analysis - Frequently Asked Questions How were Meredith's earnings last quarter? Meredith Co. (NYSE:MDP) posted its quarterly earnings results on Thursday, October, 28th. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.68 by $0.18. The company earned $708.60 million during the quarter, compared to analyst estimates of $681.84 million. Meredith had a net margin of 9.66% and a trailing twelve-month return on equity of 41.72%. The firm's revenue for the quarter was up 2.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.04 earnings per share. What is Steve Lacy's approval rating as Meredith's CEO? 231 employees have rated Meredith Chief Executive Officer Steve Lacy on Glassdoor.com. Steve Lacy has an approval rating of 78% among the company's employees. What other stocks do shareholders of Meredith own? Based on aggregate information from My MarketBeat watchlists, some companies that other Meredith investors own include AT&T (T), Verizon Communications (VZ), AbbVie (ABBV), Exxon Mobil (XOM), Cisco Systems (CSCO), Chevron (CVX), Energy Transfer (ET), Pfizer (PFE), Gilead Sciences (GILD) and Altria Group (MO). This page (NYSE:MDP) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressProtect Your Bank Account Before It’s Too LateWeiss RatingsJeff Bezos Just Humiliated Elon MuskInvestorPlace4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Meredith Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
